Cresco Labs Inc. (CL.CN)
CAD 1.23
(-1.6%)
CAD 1.23
(-1.6%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 579.32 Million USD | 5.17% |
| 2022 | 550.83 Million USD | 37.3% |
| 2021 | 401.19 Million USD | 83.83% |
| 2020 | 218.24 Million USD | 376.8% |
| 2019 | 45.77 Million USD | 134.95% |
| 2018 | -130.95 Million USD | -390.2% |
| 2017 | -26.71 Million USD | -3520.1% |
| 2016 | -737.96 Thousand USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 103.69 USD | 101.98% |
| 2013 | -5223.82 USD | -7173.15% |
| 2012 | -71.82 USD | 99.57% |
| 2011 | -16.68 Thousand USD | -109.15% |
| 2010 | 182.37 Thousand USD | 126.53% |
| 2009 | 80.5 Thousand USD | 1333.53% |
| 2008 | -6526.66 USD | 97.59% |
| 2007 | -271.22 Thousand USD | -776.71% |
| 2006 | -30.93 Thousand USD | 90.14% |
| 2005 | -313.74 Thousand USD | 74.59% |
| 2004 | -1.23 Million USD | -923.01% |
| 2003 | 150.05 Thousand USD | -7.1% |
| 2002 | 161.52 Thousand USD | -31.42% |
| 2001 | 235.51 Thousand USD | 6329.85% |
| 2000 | -3780.43 USD | 30.03% |
| 1999 | -5403.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 569.86 Million USD | -1.63% |
| 2024 Q2 | 569.84 Million USD | -0.0% |
| 2023 Q1 | 587.18 Million USD | 6.6% |
| 2023 Q4 | 579.32 Million USD | -0.04% |
| 2023 Q3 | 579.53 Million USD | -2.29% |
| 2023 Q2 | 593.13 Million USD | 1.01% |
| 2023 FY | 579.32 Million USD | 5.17% |
| 2022 Q2 | 543.04 Million USD | 17.75% |
| 2022 Q3 | 546.59 Million USD | 0.65% |
| 2022 Q4 | 550.83 Million USD | 0.77% |
| 2022 FY | 550.83 Million USD | 37.3% |
| 2022 Q1 | 461.19 Million USD | 14.96% |
| 2021 Q1 | 122.93 Million USD | -43.67% |
| 2021 Q2 | 282.34 Million USD | 129.67% |
| 2021 FY | 401.19 Million USD | 83.83% |
| 2021 Q4 | 401.19 Million USD | 14.51% |
| 2021 Q3 | 350.36 Million USD | 24.09% |
| 2020 Q2 | 214.52 Million USD | 17.5% |
| 2020 Q3 | 221.2 Million USD | 3.12% |
| 2020 FY | 218.24 Million USD | 376.8% |
| 2020 Q4 | 218.24 Million USD | -1.34% |
| 2020 Q1 | 182.57 Million USD | 298.86% |
| 2019 Q3 | -23.52 Million USD | -95.57% |
| 2019 Q1 | -56.13 Million USD | 57.25% |
| 2019 Q2 | -12.02 Million USD | 78.57% |
| 2019 Q4 | 45.77 Million USD | 294.59% |
| 2019 FY | 45.77 Million USD | 134.95% |
| 2018 FY | -130.95 Million USD | -390.2% |
| 2018 Q3 | -73.15 Thousand USD | 99.76% |
| 2018 Q1 | 27.04 Million USD | 201.23% |
| 2018 Q2 | -30.9 Million USD | -214.26% |
| 2018 Q4 | -131.3 Million USD | -179379.75% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q4 | -26.71 Million USD | 0.0% |
| 2017 FY | -26.71 Million USD | -3520.1% |
| 2017 Q1 | 1.3 Million USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | -737.96 Thousand USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q2 | 225.23 USD | 32.1% |
| 2015 FY | - USD | -100.0% |
| 2015 Q1 | 170.49 USD | 64.43% |
| 2015 Q4 | - USD | -100.0% |
| 2015 Q3 | 279.16 USD | 23.95% |
| 2014 FY | 103.69 USD | 101.98% |
| 2014 Q1 | -5307.55 USD | -1.6% |
| 2014 Q2 | -168.66 USD | 96.82% |
| 2014 Q3 | 58.93 USD | 134.94% |
| 2014 Q4 | 103.69 USD | 75.93% |
| 2013 Q4 | -5223.82 USD | -3956.08% |
| 2013 Q3 | -128.79 USD | 91.26% |
| 2013 FY | -5223.82 USD | -7173.15% |
| 2013 Q1 | -1110.74 USD | -1446.49% |
| 2013 Q2 | -1474.18 USD | -32.72% |
| 2012 Q3 | - USD | 100.0% |
| 2012 Q4 | -71.82 USD | 0.0% |
| 2012 FY | -71.82 USD | 99.57% |
| 2012 Q1 | -4121.23 USD | 75.29% |
| 2012 Q2 | -434.22 USD | 89.46% |
| 2011 Q4 | -16.68 Thousand USD | 32.04% |
| 2011 FY | -16.68 Thousand USD | -109.15% |
| 2011 Q3 | -24.54 Thousand USD | 44.0% |
| 2011 Q2 | -43.83 Thousand USD | -120.75% |
| 2011 Q1 | 211.25 Thousand USD | 15.84% |
| 2010 Q4 | 182.37 Thousand USD | 3.6% |
| 2010 Q1 | 116.36 Thousand USD | 44.54% |
| 2010 Q2 | 170.48 Thousand USD | 46.51% |
| 2010 Q3 | 176.03 Thousand USD | 3.26% |
| 2010 FY | 182.37 Thousand USD | 126.53% |
| 2009 Q4 | 80.5 Thousand USD | -29.33% |
| 2009 Q1 | -7221.18 USD | -10.64% |
| 2009 Q2 | -2325.02 USD | 67.8% |
| 2009 Q3 | 113.91 Thousand USD | 4999.57% |
| 2009 FY | 80.5 Thousand USD | 1333.53% |
| 2008 Q2 | -36.06 Thousand USD | 19.77% |
| 2008 Q3 | -38.8 Thousand USD | -7.6% |
| 2008 Q1 | -44.95 Thousand USD | 83.43% |
| 2008 FY | -6526.66 USD | 97.59% |
| 2008 Q4 | -6526.66 USD | 83.18% |
| 2007 FY | -271.22 Thousand USD | -776.71% |
| 2007 Q4 | -271.22 Thousand USD | 69.69% |
| 2007 Q3 | -894.89 Thousand USD | 14.7% |
| 2007 Q2 | -1.04 Million USD | -2764.72% |
| 2007 Q1 | 39.37 Thousand USD | 227.26% |
| 2006 Q3 | -79.9 Thousand USD | 50.27% |
| 2006 Q2 | -160.68 Thousand USD | 47.55% |
| 2006 Q1 | -306.32 Thousand USD | 2.36% |
| 2006 FY | -30.93 Thousand USD | 90.14% |
| 2006 Q4 | -30.93 Thousand USD | 61.28% |
| 2005 Q3 | -628.41 Thousand USD | -168.97% |
| 2005 Q1 | -585.63 Thousand USD | 52.58% |
| 2005 Q2 | -233.63 Thousand USD | 60.11% |
| 2005 Q4 | -313.74 Thousand USD | 50.07% |
| 2005 FY | -313.74 Thousand USD | 74.59% |
| 2004 Q1 | -132.56 Thousand USD | -188.35% |
| 2004 Q2 | 3430.00 USD | 102.59% |
| 2004 Q3 | -184.64 Thousand USD | -5483.29% |
| 2004 FY | -1.23 Million USD | -923.01% |
| 2004 Q4 | -1.23 Million USD | -568.81% |
| 2003 FY | 150.05 Thousand USD | -7.1% |
| 2003 Q1 | -734.73 USD | -100.45% |
| 2003 Q4 | 150.05 Thousand USD | -6.64% |
| 2003 Q3 | 160.72 Thousand USD | -7.5% |
| 2003 Q2 | 173.75 Thousand USD | 23748.29% |
| 2002 Q2 | 110.84 Thousand USD | -52.57% |
| 2002 Q3 | 113.92 Thousand USD | 2.78% |
| 2002 Q4 | 161.52 Thousand USD | 41.78% |
| 2002 FY | 161.52 Thousand USD | -31.42% |
| 2002 Q1 | 233.67 Thousand USD | 0.0% |
| 2001 FY | 235.51 Thousand USD | 6329.85% |
| 2000 FY | -3780.43 USD | 30.03% |
| 1999 FY | -5403.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.13 Thousand CAD | -70025.186% |
| Ayurcann Holdings Corp. | 69.97 Thousand CAD | -827759.787% |
| Blueberries Medical Corp. | -805.35 Thousand CAD | 72034.578% |
| The BC Bud Corporation | 225.15 Thousand CAD | -257204.144% |
| BioNxt Solutions Inc. | 4.53 Million CAD | -12687.286% |
| CordovaCann Corp. | 6.13 Million CAD | -9349.166% |
| Christina Lake Cannabis Corp. | 4.62 Million CAD | -12417.602% |
| Captor Capital Corp. | -5.41 Million CAD | 10807.361% |
| City View Green Holdings Inc. | 1.49 Million CAD | -38567.598% |
| 1CM Inc. | 3.31 Million CAD | -17375.826% |
| Global Hemp Group Inc. | 3.55 Million CAD | -16209.35% |
| Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | -3898.259% |
| IM Cannabis Corp. | 11.96 Million CAD | -4740.237% |
| Lobe Sciences Ltd. | 192.35 Thousand CAD | -301084.299% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | -23317.77% |
| Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 9894.218% |
| Nextleaf Solutions Ltd. | -449.15 Thousand CAD | 129082.329% |
| Ovation Science Inc. | 143.76 Thousand CAD | -402865.931% |
| Pharmadrug Inc. | 1.2 Million CAD | -47909.6% |
| Captiva Verde Wellness Corp. | 186.26 Thousand CAD | -310931.891% |
| RAMM Pharma Corp. | -4.71 Million CAD | 12395.554% |
| RIV Capital Inc. | -101.38 Million CAD | 671.424% |
| Revive Therapeutics Ltd. | -797.85 Thousand CAD | 72711.142% |
| Red White & Bloom Brands Inc. | 259.87 Million CAD | -122.921% |
| SLANG Worldwide Inc. | 20.83 Million CAD | -2681.04% |
| 1933 Industries Inc. | 16.47 Million CAD | -3415.667% |
| Red Light Holland Corp. | -13.56 Million CAD | 4371.928% |
| Top Strike Resources Corp. | 13.24 Million CAD | -4272.842% |
| Xebra Brands Ltd. | -102.41 Thousand CAD | 565750.569% |
| Adastra Holdings Ltd. | 2.2 Million CAD | -26181.472% |